Have a personal or library account? Click to login
Biomarkers in heart failure: from the bedside back to biology Cover

Biomarkers in heart failure: from the bedside back to biology

Open Access
|Jul 2018

References

  1. 1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cle-land JG, Coats AJ et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37:2129–200. DOI: 10.1093/eurheartj/ehw12810.1093/eurheartj/ehw12827206819
  2. 2. Katz AM, Konstam MA, The Neurohormonal Response in Heart Failure: Functional Signaling in Katz AM, Konstam MA, Geart Failure: Patophysiology, Molecular Biology and Clinical Managemeny, 2th ed, Lippincott Williams & Wilkins, Philadelphia 2009, pg. 89-133.
  3. 3. WHO International Programme on Chemical Safety. Biomarkers in Risk Assessment: Validity and Validation. 2001. Retrieved from http://www.inchem.org/documents/ehc/ehc/ehc222.htm
  4. 4. Braunwald E. Biomarkers in Heart Failure. N Engl J Med 2008;358:2148-59. DOI: 10.1056/NEJMra080023910.1056/NEJMra080023918480207
  5. 5. Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, Felker GM, et al. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2017;135(22):e1054-e91. DOI: 10.1161/CIR.000000000000049010.1161/CIR.000000000000049028446515
  6. 6. Pop C, Crişan GC, Loghin F, Mogoşan CI. Advances in the detection and quantification of candidate and established biomarkers in heart failure. Rev Romana Med Lab. 2013;21(3):255-65. DOI: 10.2478/rrlm-2013-002910.2478/rrlm-2013-0029
  7. 7. Zdrenghea DT, Ilea M, Zdrenghea MD, Sitar-Tǎut AV, Pop D. The Effects of Maximal and Submaximal Exercise Testing on NT-proBNP Levels in Patients with Systolic Heart Failure. Rev Romana Med Lab. 2014;22(1):25-33. DOI: 10.2478/rrlm-2014-000810.2478/rrlm-2014-0008
  8. 8. Goidescu CM, Anton FP, Leucuța DC, Mircea PA, Vida-Simiti LA. Serum level of apelin-13 negatively correlated with NT-proBNP in heart failure patients. Rev Romana Med Lab. 2016;24(4):399-412. DOI: 10.1515/rrlm-2016-003510.1515/rrlm-2016-0035
  9. 9. Lupu A, Lupu S, Agoston-Coldea L. Is galectin-3 a promoter of ventricular dysfunction?. Rev Romana Med Lab. 2018;26(1):21-36. DOI: 10.2478/rrlm-2018-000110.2478/rrlm-2018-0001
  10. 10. Iliesiu A, Campeanu A, Marta D, Parvu I, Gheorghe G. Uric Acid, Oxidative Stress and Inflammation in Chronic Heart Failure with Reduced Ejection Fraction. Rev Romana Med Lab. 2015;23(4):397-405. DOI: 10.1515/rrlm-2015-003910.1515/rrlm-2015-0039
  11. 11. Antohi EL, Tatu Chitoiu G, Ambrosy AP, Coman IM, Vinereanu D, Collins SP et al. Rationale and Design of a Prospective, Multicenter, Observational Study Evaluating Iron Deficiency in Patients Hospitalized for Heart Failure (FERIC-RO). Rev Romana Med Lab. 2018;26(3):271-81. DOI:10.2478/rrlm-2018-002210.2478/rrlm-2018-0022
DOI: https://doi.org/10.2478/rrlm-2018-0031 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624
Language: English
Page range: 267 - 270
Submitted on: Jul 12, 2018
|
Accepted on: Jul 18, 2018
|
Published on: Jul 31, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2018 Yasmin Rustamova, Dan Dobreanu, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.